Aims and Scope of Current Pharmaceutical Design
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less
Key Metrics
CiteScore 

5.8
H-Index 

176
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.73
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Design
Current Pharmaceutical Design Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Design ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Design
Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
- 25 Jul 2026
- Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
- 25 Jul 2026
- Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
- 25 Jul 2026
- Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
- 24 Jul 2026
- Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
- 23 Jul 2026
- Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
- 23 Jul 2026
- Current pharmaceutical design
Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
- 25 Jul 2026
- Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
- 25 Jul 2026
- Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
- 25 Jul 2026
- Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
- 24 Jul 2026
- Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
- 23 Jul 2026
- Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
- 23 Jul 2026
- Current pharmaceutical design